BGM Group Stock Price, News & Analysis

BGM Group (NASDAQ: BGM) has completed its acquisition of YX Management Company, an intelligent mobility technology platform, on April 25, 2025. The transaction, valued at US$95.0 million, was executed through the issuance of 47.5 million Class A ordinary shares to YX's shareholders, who now own 32.6% of BGM's equity interests and 2.2% of total voting power.

This strategic acquisition enhances BGM's AI-driven transformation, strengthening its capabilities in large-scale operations, digital infrastructure, and technology commercialization. YX's expertise in business model optimization and cross-industry resource integration will support BGM's intelligent platform development across insurance, mobility, and digital services sectors.

BGM Group (Nasdaq: BGM) has announced the acquisition of Wonder Dragon Global through a share-based transaction valued at RMB550 million. The deal involves issuing 38,165,290 Class A ordinary shares at $2 per share, with completion expected in Q2 2025.

Wonder Dragon brings over 3,000 metric tons of premium Qingzhuan dark tea inventory (1,670 tons raw materials, 1,350 tons finished products) to BGM Group's portfolio. The acquisition aims to strengthen BGM's healthcare sector presence by combining Wonder Dragon's tea resources with BGM's AI technology and biotechnology platform.

The company plans to develop new health-focused products, including ginseng and goji berry Qingzhuan dark tea variants, while optimizing production efficiency and exploring medicinal applications through its AI-powered platform.

BGM Group (NASDAQ: BGM) has announced the acquisition of YX Management Company in a stock-based transaction valued at US$95.0 million. The deal involves issuing 47.5 million class A ordinary shares, giving YX shareholders a 32.8% stake in BGM's total shares and 2.2% voting power.

The acquisition, set to complete by June 2025, aims to enhance BGM's intelligent platform DuXiaoBao through YX's expertise in AI and digital infrastructure. The YX team includes veterans from Alibaba and Didi, with experience in major projects like Taobao Mobile, Fliggy Travel, and China's national health code system.

The integration focuses on leveraging YX's capabilities in scalable operations, AI commercialization, and complex system architecture to accelerate BGM's AI-driven strategic upgrade and business expansion.

BGM Group (NASDAQ: BGM) announced significant leadership changes effective March 1, 2025. Founder and Chairman Zhanchang Xin will step down, with current CEO Chen Xin assuming the Chairman position. The transition marks a strategic shift towards technological transformation.

Chen Xin, who became CEO in May 2024, brings extensive experience in autonomous driving algorithms and AI technology, holding degrees from Sichuan University and the National University of Singapore. The company also appointed Lin Zhang as an independent director and chairman of the compensation committee, replacing Ming Jing. Zhang's background includes roles at Geely Automobile Research Institute and expertise in AI model architecture.

This board reshuffle represents BGM's strategic move to embrace technological innovation and market expansion, with the new leadership focused on accelerating the company's transformation and creating shareholder value.

BGM Group (Nasdaq: BGM) has established the 'Duxiaobao Management Committee' to accelerate its AI strategy in the insurance industry. The committee appointed Li Yuqing as Duxiaobao CEO, alongside several vice presidents including Li Jun, Ren Yong, Zhou Xin, and Tan Yinghua.

The committee brings together industry experts with diverse backgrounds: Li Yuqing, former senior executive at Didi Chuxing; Li Jun, an insurance technology expert; Ren Yong, with 15 years of insurance intermediary experience; Zhou Xin, former Alibaba product expert; and Tan Yinghua, a Microsoft MVP.

The initiative aims to leverage AI technology to transform insurance operations, focusing on automating policy transactions and enhancing operational efficiency. This strategic move is designed to allow insurance brokers to focus on core business areas while reducing manual transaction handling.

BGM Group (Nasdaq: BGM) has completed the acquisition of AIX Inc.'s intelligent platform, marking its entry into AI technology and financial/insurance services. Through the acquisition of RONS Technology and Xinbao Investment, BGM aims to integrate intelligent technology with biopharmaceuticals, strengthening its position at the intersection of healthcare technology and insurance technology.

The strategic move enables BGM to offer comprehensive health and insurance service solutions while pioneering the synergistic development of healthcare, pharmaceuticals, and insurance globally. The company plans to leverage its expertise in intelligence technology to enhance digital capabilities and adapt to pharmaceutical industry trends.

BGM Group has acquired Rongshu Technology and Xinbao Investment Company from AIX Corp (AIFU) for $140 million, strengthening its AI-driven insurance business. Under CEO Xin Chen's leadership, the company is transitioning from traditional pharmaceuticals to include AI-powered insurance solutions through the Duxiaobao platform, developed with AIFU and Baidu.

The acquisition makes AIFU a BGM shareholder and positions BGM to expand globally through the Duxiaobao data platform. The company is focusing on dual growth engines: AI insurance brokerage and health/wellness services, particularly targeting the aging population market. BGM's stock showed significant movement with a 13.49% surge on December 2, 2024, though the company remains undervalued according to the release.

BGM Group (NASDAQ: BGM) has strengthened its strategic partnership with Jointown Pharmaceutical Group through a new cooperation agreement focused on licorice fluid extract and Gandixin products. The meeting, led by BGM's Chairman Xin Zhanchang and Jointown's Honorary Vice Chairman Liu Shulin, highlighted the synergies between BGM's R&D capabilities and Jointown's extensive sales network.

The collaboration leverages BGM's subsidiary Qilianshan Pharmaceutical's research and production expertise with Jointown's comprehensive distribution system. Both companies discussed market demand, quality control, and sales channel expansion for licorice-based products, anticipating growing consumer demand for high-quality pharmaceutical products.

AIX Inc. (NASDAQ:AIFU) has completed a strategic asset restructuring worth $140 million, exchanging assets including the Duxiaobao AI insurance platform for a 72% stake in BGM Group. The company reported total revenue of $3.198 billion (up 14.98% YoY) and net profit of $289 million (up 237.25% YoY) as of December 31, 2023. The restructuring combines AIFU's insurance expertise with BGM's pharmaceutical leadership, positioning them in both AI insurance and healthcare sectors. The Duxiaobao platform, built on Baidu's big data capabilities, aims to provide intelligent insurance solutions. With a current market value of $76 million and a P/E ratio of 3.5x, AIFU appears significantly undervalued compared to industry peers.